Editorial: Reviews and advances in inflammatory diseases and the tumor necrosis factor

Editorial: Reviews and advances in inflammatory diseases and the tumor necrosis factor

Bibliographic Details
Main Author:	Cristian R. Smulski
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	TNF inflammation signalling cell death disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2024.1399804/full

Similar Items

Tumor necrosis factor is a necroptosis-associated alarmin
by: Francesca Pinci, et al.
Published: (2022-12-01)

Tumor Necrosis Factor: What Is in a Name?
by: Xinming Wang, et al.
Published: (2022-10-01)

Effects of bovine tumor necrosis factor alpha decoy receptors on cell death and inflammatory cytokine kinetics: potential for bovine inflammation therapy
by: Sotaro Fujisawa, et al.
Published: (2019-02-01)

Comparison of Apoptosis, Circulating Levels of Tumor Necrosis Factor-α and Tumor Necrosis Factor Type-I Receptor in Iranian Patients with Sepsis and Normal Controls
by: MA Boyer, et al.
Published: (2010-04-01)

Comparison of apoptosis, circulating levels of tumor necrosis factor-α and tumor necrosis factor type-I receptor in Iranian patients with sepsis and normal controls
by: MM Amiri, et al.
Published: (2010-03-01)

Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects
by: Portia Gough, et al.
Published: (2020-11-01)

Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily
by: Kirstin Kucka, et al.
Published: (2021-02-01)

TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases
by: Juliane Totzke, et al.
Published: (2020-09-01)

Risk factors for tuberculosis in inflammatory bowel disease: anti-tumor necrosis factor and hospitalization
by: Sabino Riestra, et al.

Association of Tumor Necrosis Factor Alpha Gene Polymorphisms with Inflammatory Bowel Disease in Iran.
by: Nosratollah Naderi, et al.
Published: (2014-05-01)

Inhibitors of tumor necrosis factor-a and mechanisms of their action
by: Bufan Biljana, et al.
Published: (2020-01-01)

Entamoeba histolytica – tumor necrosis factor: a fatal attraction
by: Serge Ankri
Published: (2015-07-01)

Widely Used Mutants of eiger, Encoding the Drosophila Tumor Necrosis Factor, Carry Additional Mutations in the NimrodC1 Phagocytosis Receptor
by: Albana Kodra, et al.
Published: (2020-12-01)

Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells
by: Hideki Kitaura, et al.
Published: (2022-01-01)

OTULIN deficiency in ORAS causes cell type‐specific LUBAC degradation, dysregulated TNF signalling and cell death
by: Rune Busk Damgaard, et al.
Published: (2019-03-01)

A longitudinal single-cell therapeutic atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease
by: Thomas, T
Published: (2023)

Editorial: TNFR Superfamily Oligomerization and Signaling
by: Olivier Micheau, et al.
Published: (2021-04-01)

Elevated levels of plasma tumor necrosis factor alpha in patients with pseudoexfoliation glaucoma
by: Kondkar AA, et al.
Published: (2018-01-01)

Tumor necrosis factor receptor‐2 signaling pathways promote survival of cancer stem‐like CD133+ cells in clear cell renal carcinoma
by: John R. Bradley, et al.
Published: (2020-02-01)

Tumor necrosis factor gene polymorphism rs1800629 in patients with atherosclerotic cardiovascular diseases: A review
by: Elena V. Khazova, et al.
Published: (2023-10-01)

The Exacerbating Effects of the Tumor Necrosis Factor in Cardiovascular Stenosis: Intimal Hyperplasia
by: Chandra Shekhar Boosani, et al.
Published: (2024-04-01)

The pro-inflammatory cytokine Tumor Necrosis Factor alpha (TNF-α) in Diabetic Nephropathy
by: Alia KH Mahmoud, et al.
Published: (2024-07-01)

Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter]
by: Lienggonegoro LA, et al.
Published: (2023-09-01)

The Role of Structural Bioinformatics in Understanding Tumor Necrosis Factor α-Interacting Protein Mechanisms in Chronic Inflammatory Diseases: A Review
by: Luana Luiza Bastos, et al.
Published: (2024-01-01)

Microarray analysis revealing common and distinct functions of promyelocytic leukemia protein (PML) and tumor necrosis factor alpha (TNF<it>α</it>) signaling in endothelial cells
by: Cheng Xiwen, et al.
Published: (2012-09-01)

Retinal Inflammation, Cell Death and Inherited Retinal Dystrophies
by: Lorena Olivares-González, et al.
Published: (2021-02-01)

Gastroenterologists Adherence to Tumor Necrosis Factor Antagonist Combination Therapy in Inflammatory Bowel Disease
by: Israa Abdullah, et al.
Published: (2021-09-01)

Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Response to Letter]
by: Ye J, et al.
Published: (2023-09-01)

Association of increased levels of plasma tumor necrosis factor alpha with primary open-angle glaucoma
by: Kondkar AA, et al.
Published: (2018-04-01)

Antitumor necrosis factor treatment for pediatric inflammatory bowel disease
by: Darja Urlep, et al.
Published: (2013-10-01)

Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review
by: Jean-Luc Davignon, et al.
Published: (2018-10-01)

Comparison of Conventional Inflammatory Parameters with Tumor Necrosis Factor- α Levels in Different Stages of Diabetic Retinopathy and Non-Diabetic Controls
by: Metin Guclu, et al.
Published: (2015-09-01)

Thalidomide inhibition of perturbed vasculature and glial-derived tumor necrosis factor-α in an animal model of inflamed Alzheimer’s disease brain
by: Jae K. Ryu, et al.
Published: (2008-02-01)

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
by: Dan-in Jang, et al.
Published: (2021-03-01)

Changes of Tumor Necrosis Factor- Alpha Gene Expression in Hippocampus of Rats after Brain Stroke and Endurance Training
by: Roghaieh Ahmadi, et al.
Published: (2020-04-01)

Tumor necrosis factor inhibition attenuates white matter gliosis after systemic inflammation in preterm fetal sheep
by: Robert Galinsky, et al.
Published: (2020-03-01)

Tumour necrosis factor alpha downregulates human hemojuvelin expression via a novel response element within its promoter
by: Salama Mohamed, et al.
Published: (2012-09-01)

Imbalance of the “ligandreceptor” tumor necrosis factor αsystem and TNFRI expression in thyroid tissue in patients with Graves' disease
Published: (2013-09-01)

Tumor Necrosis Factor’s Pathway in Crohn’s Disease: Potential for Intervention
by: Cristiano Pagnini, et al.
Published: (2021-09-01)

Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies
by: Sara Ferraro, et al.
Published: (2019-03-01)